ArticlePharmaceuticals (Basel, Switzerland)2025

Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations.

Tilal Elsaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.